Cargando…

Aberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy

Detalles Bibliográficos
Autores principales: Liu, Yudong, Mao, Xia, Ma, Zhaochen, Chen, Wenjia, Guo, Xiaodong, Yu, Lingxiang, Deng, Xinxin, Jiang, Funeng, Li, Taixian, Lin, Na, Zhang, Yanqiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815183/
https://www.ncbi.nlm.nih.gov/pubmed/35120500
http://dx.doi.org/10.1186/s12943-021-01493-6
_version_ 1784645229479985152
author Liu, Yudong
Mao, Xia
Ma, Zhaochen
Chen, Wenjia
Guo, Xiaodong
Yu, Lingxiang
Deng, Xinxin
Jiang, Funeng
Li, Taixian
Lin, Na
Zhang, Yanqiong
author_facet Liu, Yudong
Mao, Xia
Ma, Zhaochen
Chen, Wenjia
Guo, Xiaodong
Yu, Lingxiang
Deng, Xinxin
Jiang, Funeng
Li, Taixian
Lin, Na
Zhang, Yanqiong
author_sort Liu, Yudong
collection PubMed
description
format Online
Article
Text
id pubmed-8815183
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88151832022-02-07 Aberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy Liu, Yudong Mao, Xia Ma, Zhaochen Chen, Wenjia Guo, Xiaodong Yu, Lingxiang Deng, Xinxin Jiang, Funeng Li, Taixian Lin, Na Zhang, Yanqiong Mol Cancer Letter to the Editor BioMed Central 2022-02-04 /pmc/articles/PMC8815183/ /pubmed/35120500 http://dx.doi.org/10.1186/s12943-021-01493-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter to the Editor
Liu, Yudong
Mao, Xia
Ma, Zhaochen
Chen, Wenjia
Guo, Xiaodong
Yu, Lingxiang
Deng, Xinxin
Jiang, Funeng
Li, Taixian
Lin, Na
Zhang, Yanqiong
Aberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy
title Aberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy
title_full Aberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy
title_fullStr Aberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy
title_full_unstemmed Aberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy
title_short Aberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy
title_sort aberrant regulation of lncrna tug1-microrna-328-3p-srsf9 mrna axis in hepatocellular carcinoma: a promising target for prognosis and therapy
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815183/
https://www.ncbi.nlm.nih.gov/pubmed/35120500
http://dx.doi.org/10.1186/s12943-021-01493-6
work_keys_str_mv AT liuyudong aberrantregulationoflncrnatug1microrna3283psrsf9mrnaaxisinhepatocellularcarcinomaapromisingtargetforprognosisandtherapy
AT maoxia aberrantregulationoflncrnatug1microrna3283psrsf9mrnaaxisinhepatocellularcarcinomaapromisingtargetforprognosisandtherapy
AT mazhaochen aberrantregulationoflncrnatug1microrna3283psrsf9mrnaaxisinhepatocellularcarcinomaapromisingtargetforprognosisandtherapy
AT chenwenjia aberrantregulationoflncrnatug1microrna3283psrsf9mrnaaxisinhepatocellularcarcinomaapromisingtargetforprognosisandtherapy
AT guoxiaodong aberrantregulationoflncrnatug1microrna3283psrsf9mrnaaxisinhepatocellularcarcinomaapromisingtargetforprognosisandtherapy
AT yulingxiang aberrantregulationoflncrnatug1microrna3283psrsf9mrnaaxisinhepatocellularcarcinomaapromisingtargetforprognosisandtherapy
AT dengxinxin aberrantregulationoflncrnatug1microrna3283psrsf9mrnaaxisinhepatocellularcarcinomaapromisingtargetforprognosisandtherapy
AT jiangfuneng aberrantregulationoflncrnatug1microrna3283psrsf9mrnaaxisinhepatocellularcarcinomaapromisingtargetforprognosisandtherapy
AT litaixian aberrantregulationoflncrnatug1microrna3283psrsf9mrnaaxisinhepatocellularcarcinomaapromisingtargetforprognosisandtherapy
AT linna aberrantregulationoflncrnatug1microrna3283psrsf9mrnaaxisinhepatocellularcarcinomaapromisingtargetforprognosisandtherapy
AT zhangyanqiong aberrantregulationoflncrnatug1microrna3283psrsf9mrnaaxisinhepatocellularcarcinomaapromisingtargetforprognosisandtherapy